Literature DB >> 12399665

Topical treatment of pyoderma gangraenosum.

Joerg Wenzel1, Rainer Gerdsen, Wolfgang Phillipp-Dormston, Thomas Bieber, Manfred Uerlich.   

Abstract

The treatment of pyoderma gangraenosum (PG) is still a therapeutic challenge. Although several drugs such as corticosteroids, dapsone, clofazimine, azathioprine, tacrolimus and cyclosporine A have been shown to be effective in this disease, side-effects of these agents limit their systemic use in seriously ill patients. In recent years, topical treatment of the disease has gained attention. Several reports show an improvement of cutaneous lesions of PG following topical treatment. These earlier reports as well as our own observations suggest that topical therapeutic regimens can be a useful and safe alternative to systemic immunosuppressive therapy in the treatment of PG. We give a review about these topically used drugs and the mechanisms probably involved. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399665     DOI: 10.1159/000065843

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  12 in total

Review 1.  Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?

Authors:  Fernando Tavarela Veloso
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

2.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

3.  [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].

Authors:  L Trémezaygues; R Schmaltz; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

4.  Pyoderma gangrenosum - a guide to diagnosis and management .

Authors:  Christina George; Florence Deroide; Malcolm Rustin
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

Review 5.  Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.

Authors:  Thrasivoulos George Tzellos; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2007-12-20       Impact factor: 2.953

6.  Diagnosis and management of parastomal pyoderma gangrenosum.

Authors:  Xian-Rui Wu; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-04-19

Review 7.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012

8.  Facial pyoderma gangrenosum in senescence.

Authors:  Dorothea Kratzsch; Mirjana Ziemer; Linda Milkova; Justinus A Wagner; Jan C Simon; Michael Kendler
Journal:  Case Rep Dermatol       Date:  2013-10-11

9.  Peritoneal Dialysis Exit Site Pyoderma Gangrenosum: A Case Report.

Authors:  Salman Anwar; Karen Holfeld; Bhanu Prasad
Journal:  Case Rep Nephrol Dial       Date:  2018-11-14

10.  Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis C.

Authors:  Mohsen Pourmorteza; Fady Tawadros; Gilbert Bader; Mohamed Al-Tarawneh; Emilie Cook; Wael Shams; Mark Young
Journal:  Am J Case Rep       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.